Advertisement

Topics

Merck looks to catch Bristol with new melanoma data for Keytruda

06:30 EDT 16 Apr 2018 | BioPharmaDive

In one of several successes for Keytruda at AACR, the immunotherapy helped reduce the risk of melanoma recurring following surgery

Original Article: Merck looks to catch Bristol with new melanoma data for Keytruda

NEXT ARTICLE

More From BioPortfolio on "Merck looks to catch Bristol with new melanoma data for Keytruda"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...